'Primed to Progress,' But More Work Needed on Neuropsychiatric, Genetic Research Effort by California Stem Cell Agency
It's part of a $1.5 billion neuro disease program required by voters
The California stem cell agency said this week that the possibility of genetic treatment of neuropsychiatric disorders is “primed for progress.”
But it also said that it will take a little longer before its pl…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.